Zoster in patients infected with HIV: A review

American Journal of the Medical Sciences

Volumn 321, Issue 6, 2001, Pages 372-380

  Vafai, Abbas ^a   Berger, Mitchell ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

AIDS; Chickenpox; Herpes zoster; HIV; Shineles; Varicella zoster virus; Zoster

Indexed keywords

ANTIVIRUS AGENT; CHICKENPOX VACCINE; IMMUNOGLOBULIN;

ADULT; AGED; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; INFECTION CONTROL; REVIEW; VIRAL SKIN DISEASE;

ADULT; AGED; ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHICKENPOX VACCINE; CHILD; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; INFECTION CONTROL; SKIN DISEASES, VIRAL;

EID: 0035377247     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200106000-00003     Document Type: Review

References (30)

1. Straus SE. Shingles: Sorrows, salves and solutions. JAMA 1993;269:1836-9.
2. Straus SE, Oxman MN. Varicella and herpes zoster. In: Freedberg IM, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine, 5th ed. Vol 2. New York: McGraw-Hill; 1999. p. 2427-50.
3. Whitley RJ. Varicella-zoster virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone; 1995. p. 1345-51.
4. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996; 9:361-81.
5. Andiman RM, Brunton SA, Lawrence L, et al. Herpes zoster: presentations and pitfalls. Patient Care 1994;28:2-11.
6. Gelb LD. Varicella-zoster virus. In: Fields BN, Knipe DM, editors. Fields virology. New York: Raven Press; 1990. p. 2011-54.
7. Weller TH, Witton HM. The etiologic agents of varicella and herpes zoster: serologice studies with the virus as propagated in vitro. J Exp Med 1958; 108:869-90.
8. Vafai A, Wellish M, Gilden DH. Expression of varicellazoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci USA 1988;85:2767-70.
9. Karbassi M, Raizman MB, Schuman JS. Herpes zoster ophthalmicus. Surv Ophthalmol 1992;36:395-410.
10. Gilden DH, Dueland AN, Devlin ME, et al. Varicellazoster virus reactivation without rash. J Infect Dis 1992;166: S30-4.
11. Meylan PRA, Miklossy J, Iten A, et al. Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash. Clin Infect Dis 1995;20:206-8.
12. Gibney MD, Leonardi CL, Glaser DA. Concurrent herpes simplex and varicella-zoster infection in an immunocompromised patient. J Am Acad Dermatol 1995;33:126-9.
13. Gilden DH, Bennett JL, Kleinscmidt-DeMasters BK, et al. The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci 1998;159:140-4.
14. Liesegang TJ. Ocular viral infections: varicella-zoster virus. In: Galasso GJ, Whitley RJ, Merigan TC, editors. Antiviral agents and human viral diseases, 4th ed. New York: Lippin-cott-Raven; 1997. p. 229-55.
15. Schmidt NJ. Further evidence for common antigens in herpes simplex and varicella-zoster viruses. J Med Virol 1982;9: 27-36.
16. Gottlieb MS, Groopman JE, Weinstein WM, et al. The acquired immunodeficiency syndrome. Ann Intern Med 1983; 99:208-20.
17. Rogers MF, Morens DF, Stewart JA, et al. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men. Part 2. Laboratory results. Ann Intern Med 1983;99:151-8.
18. Melbye M, Grossman RJ, Goedert JJ, et al. Risk of AIDS after herpes zoster. Lancet.l987;1:728-30.
19. Van De Perre P, Bakkers E, Batungwanayo J, et al. Herpes zoster in African patients: an early manifestation of HIV infection. Scand J Infect Dis 1988;20:277-82.
20. Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis 1988;157:314-18.
21. Ryder JW, Croen K, Kleinschmidt-DeMasters BK, et al. Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol 1986; 19:182-8.
22. Rogues AM, Dupon M, Ladner J, et al. Herpes zoster and human immunodeficiency virus infection: a cohort of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en Aquitaine. J Infect Dis 1993;168:245.
23. Veenstra J, Krol A, Van Pragg RM, et al. Herpes zoster immunological deterioration and disease progression in HIV-1 infection. AIDS 1995;9:1153-8.
24. Glesby MJ, Moore RD, Chaisson RE. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group. J Infect Dis 1993;168:1264-8.
25. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-805.
26. Veenstra J, Van Praag RM, Krol A, et al. Complications of varicella zoster virus reactivation in HIV-infected homosexual men. AIDS 1996;10:393-9.
27. Perronne C, Lazanas M, Leport C, et al. Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol 1990;126:1033-6.
28. Wright SW, Johnson RA. Human immunodeficiency virus in women: mucocutaneous manifestations. Clin Dermatol 1997;15:93-111.
29. Lepage P, Dabis F, Hitmana DG, et al. Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS 1991;5:295-300.
30. Alliegro MB, Dorrucci M, Pezzotti P, et al. Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Clin Infect Dis 1996;23:990-5.